SUPERNUS PHARMACEUTICALS, INC. Public Float
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Public Float of $1.69 billion as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $1.69B.
- 2024-06-30: Entity Public Float $1.41B.
- 2022-06-30: Entity Public Float $1.55B.
- 2021-06-30: Entity Public Float $1.63B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.69B 10-K · filed 2026-03-02 |
| 2024-06-30 | $1.41B 10-K · filed 2025-02-25 |
| 2022-06-30 | $1.55B 10-K · filed 2023-03-09 |
| 2021-06-30 | $1.63B 10-K · filed 2022-04-13 |
| 2020-06-30 | $1.21B 10-K · filed 2021-03-08 |
| 2019-06-30 | $1.68B 10-K · filed 2020-02-28 |
| 2018-06-30 | $3.02B 10-K · filed 2019-03-01 |
| 2017-06-30 | $2.11B 10-K · filed 2018-03-01 |
| 2016-06-30 | $966.99M 10-K · filed 2017-03-16 |
| 2015-06-30 | $659.26M 10-K/A · filed 2017-01-20 |
| 2014-06-30 | $238.32M 10-K · filed 2015-03-12 |
| 2013-06-30 | $49.11M 10-K · filed 2014-03-21 |
| 2012-06-30 | $19.55M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |